Blood Pressure Changes Linked to Increased Risk of Cognitive Problems: Study

A recent study from Rush University, US, reveals that fluctuations in blood pressure in older adults could increase the risk of thinking and memory problems. Published in the journal Neurology, the research highlights the connection between blood pressure variability and cognitive decline, making blood pressure management an important focus for preventing conditions like Alzheimer’s disease. […]
Read more

Fortis Healthcare to Raise ₹15.50 Billion via 5-Year Bonds

Fortis Healthcare, one of India’s leading healthcare providers, plans to raise ₹15.50 billion (approximately $182.71 million) through the issuance of floating rate bonds maturing in five years. The move aims to strengthen its financial base and support its operational and strategic objectives. Key Details About the Bond Issue Why This Bond Issue Matters Comparison with […]
Read more

CDSCO Waives Local Clinical Trials for Drugs Approved in Select Countries

To streamline the approval process for new medicines, the Central Drugs Standard Control Organization (CDSCO) has decided to waive the requirement for local clinical trials for certain drugs approved in select countries. Union Health Minister Anupriya Patel recently shared this decision in the Lok Sabha, sparking discussions about its impact on drug availability, affordability, and safety in […]
Read more

EEG and MRI may specifically predict death among infants with hypoxic-ischemic encephalopathy: JAMA

Researchers have made a significant breakthrough in predicting the health outcomes of infants with hypoxic-ischemic encephalopathy (HIE) using EEG and MRI data. A recent study, published in JAMA Network Open by Hannah C. and colleagues, shows that combining clinical data with electroencephalography (EEG) and magnetic resonance imaging (MRI) can help accurately predict death or severe […]
Read more

WHO Grants Prequalification to Rapid Molecular TB Test

The World Health Organization (WHO) has announced the prequalification of Xpert MTB/RIF Ultra, a groundbreaking rapid molecular diagnostic test for tuberculosis (TB). This test, developed by Cepheid Inc., is designed to detect Mycobacterium tuberculosis, the bacteria causing TB, and mutations linked to rifampicin resistance, a marker of multidrug-resistant TB (MDR-TB). The test delivers accurate results […]
Read more